JP2008538494A5 - - Google Patents

Info

Publication number

JP2008538494A5

JP2008538494A5 JP2008505606A JP2008505606A JP2008538494A5 JP 2008538494 A5 JP2008538494 A5 JP 2008538494A5 JP 2008505606 A JP2008505606 A JP 2008505606A JP 2008505606 A JP2008505606 A JP 2008505606A JP 2008538494 A5 JP2008538494 A5 JP 2008538494A5

Authority

JP

Japan

Prior art keywords

xmrv

acid sequence

individual

seq

mutation

Prior art date

2006-04-07

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 241000101098 Xenotropic MuLV-related virus Species 0.000 claims 33
• 238000000034 method Methods 0.000 claims 11
• 108091028043 Nucleic acid sequence Proteins 0.000 claims 10
• 230000035772 mutation Effects 0.000 claims 10
• 150000007523 nucleic acids Chemical group 0.000 claims 10
• 241000700605 Viruses Species 0.000 claims 9
• 229920001184 polypeptide Polymers 0.000 claims 8
• 108090000765 processed proteins & peptides Proteins 0.000 claims 8
• 102000004196 processed proteins & peptides Human genes 0.000 claims 8
• 206010060862 Prostate cancer Diseases 0.000 claims 7
• 125000003275 alpha amino acid group Chemical group 0.000 claims 7
• 239000000427 antigen Substances 0.000 claims 6
• 108091007433 antigens Proteins 0.000 claims 6
• 102000036639 antigens Human genes 0.000 claims 6
• 239000003795 chemical substances by application Substances 0.000 claims 6
• 239000012634 fragment Substances 0.000 claims 6
• 208000000236 Prostatic Neoplasms Diseases 0.000 claims 5
• 239000003814 drug Substances 0.000 claims 5
• 102100027962 2-5A-dependent ribonuclease Human genes 0.000 claims 4
• 108010000834 2-5A-dependent ribonuclease Proteins 0.000 claims 4
• 229940079593 drug Drugs 0.000 claims 3
• 238000009396 hybridization Methods 0.000 claims 3
• 230000028993 immune response Effects 0.000 claims 3
• 238000004519 manufacturing process Methods 0.000 claims 3
• 108700028369 Alleles Proteins 0.000 claims 2
• 101001080057 Homo sapiens 2-5A-dependent ribonuclease Proteins 0.000 claims 2
• 230000000295 complement effect Effects 0.000 claims 2
• 230000000694 effects Effects 0.000 claims 2
• 208000020735 familial prostate carcinoma Diseases 0.000 claims 2
• 230000001939 inductive effect Effects 0.000 claims 2
• 210000002307 prostate Anatomy 0.000 claims 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 1
• 102100024233 High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A Human genes 0.000 claims 1
• 102100034343 Integrase Human genes 0.000 claims 1
• 101100070104 Mus musculus Hacl1 gene Proteins 0.000 claims 1
• 101710127370 Probable head completion protein 1 Proteins 0.000 claims 1
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims 1
• 230000002238 attenuated effect Effects 0.000 claims 1
• 238000001514 detection method Methods 0.000 claims 1
• 239000002245 particle Substances 0.000 claims 1
• 208000023958 prostate neoplasm Diseases 0.000 claims 1
• 230000001177 retroviral effect Effects 0.000 claims 1